Novartis India Limited (NOVARTIND) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE234A01025
Key metrics
- Market Cap
- ₹4,075 Cr
- P/E Ratio
- 41.72
- EPS
- 39.56
- Book Value
- 331.23
- P/B Ratio
- 4.98
- ROE
- 11.39%
- ROCE
- 11.21%
- Debt / Equity
- 0
- Net Margin
- 26.3%
- Revenue Growth
- -0.54%
- Profit Growth
- -7.65%
- Dividend Yield
- —
- 52W High
- ₹1,780.00
- 52W Low
- ₹672.25
- Market Cap Band
- small cap
- Face Value
- 5
Ratios computed from the annual results period ending 2026-03-31.
About Novartis India Limited
Novartis India Limited is involved in the pharmaceutical business in India. The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands. It also offers neuroscience products under the Tegrital and Exelon brands. Novartis India Limited was incorporated in 1947 and is headquartered in Mumbai, India. As of July 29, 2026, Novartis India Limited operates as a subsidiary of Waverise Investments Limited.
- Headquarters
- Mumbai, India
- Promoter Holding
- 58.68%
The full Novartis India Limited analysis
Create a free account to open the complete NOVARTIND deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.